Canada Markets closed

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9477-0.0418 (-4.22%)
At close: 04:00PM EST
0.9800 +0.03 (+3.41%)
After hours: 04:55PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.11
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.0800
52 Week Low 30.8800
50-Day Moving Average 31.3030
200-Day Moving Average 33.0898

Share Statistics

Avg Vol (3 month) 31.02M
Avg Vol (10 day) 3698.59k
Shares Outstanding 5125.5M
Implied Shares Outstanding 6N/A
Float 879.62M
% Held by Insiders 10.12%
% Held by Institutions 160.01%
Shares Short (Dec. 14, 2021) 41.71M
Short Ratio (Dec. 14, 2021) 42.12
Short % of Float (Dec. 14, 2021) 4N/A
Short % of Shares Outstanding (Dec. 14, 2021) 41.36%
Shares Short (prior month Nov. 14, 2021) 45.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-11,811.33%

Management Effectiveness

Return on Assets (ttm)-26.91%
Return on Equity (ttm)-63.28%

Income Statement

Revenue (ttm)1.19M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-40.30%
Gross Profit (ttm)1.74M
EBITDA -138.69M
Net Income Avi to Common (ttm)-141.86M
Diluted EPS (ttm)-1.2120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)254.14M
Total Cash Per Share (mrq)2.03
Total Debt (mrq)60.84M
Total Debt/Equity (mrq)25.22
Current Ratio (mrq)6.59
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)-103.53M
Levered Free Cash Flow (ttm)-63.97M